POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in POINT Biopharma Global Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +6 vs. Q4 2022
- Shares held
- 62.6M
- +1.47M (+2.4%) vs. Q4 2022
- Total value
- $455.0M
- +$9.47M (+2.1%) vs. Q4 2022
- New holders
- 19
- 34 more added
- Sold out
- 13
- 37 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 126 | $411.0M |
| Q2 2023 | 130 | $570.6M |
| Q1 2023 | 115 | $455.0M |
| Q4 2022 | 109 | $445.5M |
| Q3 2022 | 106 | $470.4M |
| Q2 2022 | 84 | $330.5M |
| Q1 2022 | 68 | $318.0M |
| Q4 2021 | 55 | $194.4M |
| Q3 2021 | 34 | $247.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding POINT Biopharma Global Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AQR Capital Management LLC | 10,508 | $76.4K | 0.00% | −107−1.0% | Reduced |
| ProShare Advisors LLC | 10,218 | $74.3K | 0.00% | −781−7.1% | Reduced |
| Lazard Asset Management LLC | 8,840 | $64.0K | 0.00% | +8,840 | New |
| Ameritas Investment Partners, Inc. | 6,840 | $49.7K | 0.00% | 00.0% | Unchanged |
| Amundi | 5,829 | $40.7K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 4,581 | $33.3K | 0.00% | −890−16.3% | Reduced |
| Tower Research Capital LLC (TRC) | 3,081 | $22.0K | 0.00% | +1,340+77.0% | Added |
| Advisor Group Holdings, Inc. | 2,670 | $19.4K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 2,470 | $18.0K | 0.00% | +1,528+162.2% | Added |
| FinTrust Capital Advisors, LLC | 1,000 | $7.29K | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 500 | $3.63K | 0.00% | +500 | New |
| The PNC Financial Services Group, Inc. | 200 | $1.45K | 0.00% | 00.0% | Unchanged |
| Mendota Financial Group, LLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −2,627,000−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −197,278−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −127,090−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −29,744−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −15,530−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,646−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −12,829−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −12,250−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −8,100−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,705−100.0% | Sold out |